Tesamorelin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of Tesamorelin is 26-38 minutes. This means dosing once daily is typical to maintain stable levels. The half-life directly affects how long Tesamorelin remains active and influences optimal injection timing.
What Is the Half-Life of Tesamorelin?
The half-life of Tesamorelin is 26-38 minutes. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer Tesamorelin to maintain therapeutic blood levels.
What Does Tesamorelin's Half-Life Mean for Dosing?
With a half-life of 26-38 minutes, Tesamorelin requires dosing once daily to maintain stable levels. The standard dosage of 2 mg daily via subcutaneous injection accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, Tesamorelin reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For Tesamorelin, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject Tesamorelin?
Optimal timing depends on your research goals. A half-life of 26-38 minutes means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once daily) for more stable levels throughout the day.
How Does Tesamorelin's Half-Life Compare to Similar Peptides?
Tesamorelin is a GHRH analog, growth hormone secretagogue. Its half-life of 26-38 minutes positions it with a shorter duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your Tesamorelin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Tesamorelin.
Open Calculator →Bottom Line: Tesamorelin Half-Life and Dosing
Tesamorelin has a half-life of 26-38 minutes, supporting the standard protocol of 2 mg daily dosed once daily over ongoing maintenance; demonstrated benefit to 12+ months.
Read our Tesamorelin dosage guide for complete protocol details.
Complete Guide
Tesamorelin: The FDA-Approved GHRH Analog
Related Reading
- Tesamorelin Dosage Guide
- Tesamorelin Benefits
- Tesamorelin Side Effects
- Tesamorelin Stacking Guide
- Tesamorelin Cycle Guide
- Tesamorelin Research
Research-Grade Sourcing
If you're going to research Tesamorelin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin (Synthetic GHRH analog (44 amino acid polypeptide)) is a GHRH analog, growth hormone secretagogue. Synthetic 44 amino acid GHRH analog with enhanced metabolic stability and DPP-4 protease resistance. It is researched for visceral fat reduction, body image improvement, metabolic restoration in HIV lipodystrophy.
What is the recommended Tesamorelin dosage?
Common dosages: 2 mg daily administered once daily via subcutaneous injection. Cycle length: ongoing maintenance; demonstrated benefit to 12+ months. Half-life: 26-38 minutes. Use our peptide calculator for exact reconstitution math.
What are the side effects of Tesamorelin?
Well-tolerated. Injection site reactions most common. Transient flushing, headache, dizziness possible early on. No significant metabolic derangements.
Is Tesamorelin safe?
Tesamorelin has shown a favorable safety profile in research. FDA-approved (2010) for HIV-associated lipodystrophy. Prescription medication. All research should follow appropriate safety protocols.